KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Share-based Compensation (2016 - 2025)

LifeMD filings provide 14 years of Share-based Compensation readings, the most recent being $2.7 million for Q3 2025.

  • On a quarterly basis, Share-based Compensation rose 28.57% to $2.7 million in Q3 2025 year-over-year; TTM through Dec 2025 was $5.2 million, a 32.7% decrease, with the full-year FY2025 number at $535000.0, down 95.63% from a year prior.
  • Share-based Compensation hit $2.7 million in Q3 2025 for LifeMD, up from $2.5 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $4.5 million in Q1 2022 to a low of $6000.0 in Q2 2023.
  • Median Share-based Compensation over the past 5 years was $2.7 million (2023), compared with a mean of $2.6 million.
  • Biggest five-year swings in Share-based Compensation: skyrocketed 2325.21% in 2021 and later tumbled 99.85% in 2023.
  • LifeMD's Share-based Compensation stood at $4.1 million in 2021, then plummeted by 53.9% to $1.9 million in 2022, then skyrocketed by 93.44% to $3.6 million in 2023, then dropped by 14.83% to $3.1 million in 2024, then fell by 13.04% to $2.7 million in 2025.
  • The last three reported values for Share-based Compensation were $2.7 million (Q3 2025), $2.5 million (Q1 2025), and $3.1 million (Q4 2024) per Business Quant data.